Prelude Capital Management, LLC Homology Medicines, Inc. Transaction History

Prelude Capital Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$6.01 - $8.71 $69,716 - $101,036	-11,600 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$6.02 - $9.64 $69,832 - $111,824	11,600 New	11,600 $84,000
Q4 2020 Feb 16, 2021	SELL	$8.92 - $13.29 $892 - $1,329	-100 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$9.94 - $16.59 $994 - $1,659	100 New	100 $1,000
Q3 2019 Nov 14, 2019	SELL	$14.74 - $22.28 $4,893 - $7,396	-332 Closed	0 $0

Q2 2019 Aug 14, 2019	BUY	$18.35 - $30.34 $6,092 - $10,072	332 New	332 $6,000
Q1 2019 May 15, 2019	SELL	$19.76 - $29.57 $82,339 - $123,218	-4,167 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$18.39 - $26.3 $76,631 - $109,592	4,167 New	4,167 $93,000

66.2K

Ticker FIXX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 57,402,000
Description
Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.